Personalis, Inc. (PSNL): Depreciation & Amortization
$10.05M
Year ended 2025-12-31
$9.71M
Trailing 12 months to 2026-06-30
+6.0%
3-year compound annual growth
+11.8%
5-year compound annual growth
| Period ended | Depreciation & Amortization | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $10.05M | -8.2% | 2026-02-26, From 2025-01-01 |
| 2024-12-31 | $10.94M | -3.1% | 2026-02-26, From 2024-01-01 |
| 2023-12-31 | $11.30M | +34.0% | 2025-02-27, From 2023-01-01 |
| 2022-12-31 | $8.43M | +40.2% | 2024-02-28, From 2022-01-01 |
| 2021-12-31 | $6.01M | +4.4% | 2024-02-28, From 2021-01-01 |
| 2020-12-31 | $5.76M | +21.3% | 2023-02-23, From 2020-01-01 |
| 2019-12-31 | $4.75M | +54.9% | 2022-02-24, From 2019-01-01 |
| 2018-12-31 | $3.07M | +152.1% | 2021-02-25, From 2018-01-01 |
| 2017-12-31 | $1.22M | n/a | 2020-03-25, From 2017-01-01 |
Depreciation & Amortization at similar companies
| Company | Year ended | Depreciation & Amortization | Change YoY |
|---|---|---|---|
| Personalis, Inc. (PSNL) | 2025-12-31 | $10.05M | -8.2% |
| Exagen Inc. (XGN) | 2025-12-31 | $2.10M | +23.5% |
| Biodesix Inc (BDSX) | 2025-12-31 | $5.67M | -1.8% |
| American Shared Hospital Services (AMS) | 2025-12-31 | $5.71M | -7.5% |
| BillionToOne, Inc. (BLLN) | 2025-12-31 | $6.90M | -1.4% |
| Fulgent Genetics, Inc. (FLGT) | 2025-12-31 | $24.12M | -3.2% |
| Castle Biosciences Inc (CSTL) | 2025-12-31 | $40.77M | +154.9% |
| CareDx, Inc. (CDNA) | 2025-12-31 | $15.02M | +5.8% |
| Veracyte, Inc. (VCYT) | 2025-12-31 | $21.41M | -8.7% |
Compare PSNL, XGN, BDSX, AMS side by side · Screen every company in Services-Medical Laboratories ↗